Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 29 for your search:
Cancer Type:
Breast cancer, female
Trial Type:
Prevention
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
35 and over
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
CAN-NCIC-MAP3
, PFIZER-EXEAPO-0028-150, ExCel, NCT00083174, MAP3
2.
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
Postmenopausal
Sponsor:
Other
Protocol IDs:
IBCSG-35-07
, IBCSG-35-07, BIG-1-07-SOLE, EUDRACT-2007-001370-88, NCT00553410
3.
Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
40 to 69
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
FNCLCC-ONCO-03/0701
, FNCLCC-ONCO 03/0701 - LIBER, EU-20806, NOVARTIS-FNCLCC-ONCO 03/0701, NCT00673335
4.
Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer
Phase:
Phase III
Type:
Prevention, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
ACCOG-HER-PCI
, ACCOG-HER-PCI, ISRCTN64624715, EU-20822, NCT00639366
5.
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
30 to 75
Sponsor:
Other
Protocol IDs:
GD-10-08
, NCT00808522
6.
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
21 to 48
Sponsor:
NCI
Protocol IDs:
CHNMC-IRB-02164
, NCT00080756
7.
Exemestane in Treating Postmenopausal Women at High Risk for Invasive Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
Postmenopausal
Sponsor:
NCI
Protocol IDs:
GUMC-2007-313
, NCI-04-C-0044, NCT00085072, GUMC-2007-313, GT 07-313, 2007-313
8.
Soy Protein and Breast Cancer Risk Reduction
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
30 to 40
Sponsor:
Other
Protocol IDs:
02-422
, Army's HSRRB log no. A-10926, UTMB GCRC 533, DAMD17-01-1-0417, NIH NCRR GCRC M01 RR00073, NCT00204477
9.
Soy Isoflavones and Breast Cancer Risk Reduction
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
30 to 42
Sponsor:
NCI, Other
Protocol IDs:
03-260
, UTMB GCRC #635, NIH R01-CA95545, NIH NCRR GCRC M01 RR00073, NCT00204490
10.
Phase II Trial - Breast Cancer Chemoprevention by Lovastatin
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Diagnostic, Prevention
Status:
Active
Age:
18 to 70
Sponsor:
Other
Protocol IDs:
BRSNSTU0010
, NCT00285857
11.
Simvastatin in Preventing a New Breast Cancer in Women Who Are at High Risk for a New Breast Cancer After Undergoing Surgery for Ductal Carcinoma in Situ or Stage I, Stage II, or Stage III Breast Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
JHOC-J0485
, J0485, JHOC-SKCCC-J0485, JHOC-04100404, NCT00334542
12.
Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Approved-not yet active
Age:
30 to 90
Sponsor:
Other
Protocol IDs:
102/07
, NCT00496288
13.
Study of Breast Cancer Prevention by Letrozole in High Risk Women
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
30 to 69
Sponsor:
NCI, Other
Protocol IDs:
10587
, NCT00579826
14.
Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
30 to 55
Sponsor:
NCI
Protocol IDs:
WCCC-UW-CO06101
, KUMC-HSC-10588, KUMC HSC 10588, WCCC-UWI05-6-01, NCT00853996
15.
Vitamin D in Postmenopausal Women at High Risk for Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
21 and over
Sponsor:
Other
Protocol IDs:
Protocol Dated 121308
, AAAD3638, NCT00859651
16.
Vitamin D3 for Aromatase Inhibitor Induced Arthralgias
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
11548
, NCT00867217
17.
IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer
Phase:
Phase I
Type:
Prevention
Status:
Active
Age:
40 to 75
Sponsor:
NCI
Protocol IDs:
CHNMC-IRB-03178
, NCT00100893
18.
Green Tea Extract in Treating Women With Hormone Receptor-Negative Stage I, Stage II, or Stage III Breast Cancer
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Prevention, Treatment
Status:
Active
Age:
21 to 65
Sponsor:
NCI
Protocol IDs:
MDA-MDA04-4-01
, MDA04-4-01, NCT00516243, MDA-2006-0521, CPMC-IRB-AAAB7638
19.
Atorvastatin in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
18 to 72
Sponsor:
NCI
Protocol IDs:
MDA-MDA05-6-01
, MDA05-6-01, MDA-2006-0185, NCT00637481
20.
White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
21 and over
Sponsor:
NCI
Protocol IDs:
CHNMC-07213
, 07213, NCT00709020
21.
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer
Phase:
No phase specified
Type:
Prevention
Status:
Active
Age:
40 to 70
Sponsor:
Other
Protocol IDs:
CRUK-IBIS-IIB
, EU-20227, NCT00078832, IBCSG-31-03-PREV, EUDRACT-2004-003991-12
22.
Exercise in Preventing Breast Cancer in Healthy Young Women
Phase:
No phase specified
Type:
Diagnostic, Prevention
Status:
Active
Age:
18 to 30
Sponsor:
NCI
Protocol IDs:
UMN-0505M69867
, NCT00393172
23.
Effect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweight or Obese Postmenopausal Women
Phase:
No phase specified
Type:
Behavioral study, Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
50 to 75
Sponsor:
NCI
Protocol IDs:
FHCRC-PHS-1960.00
, FHCRC-1960, PHS 1960.00, NCT00470119
24.
Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-MC0536
, MC0536, NCT00611104
25.
DAMES: Daughters And MothErS Against Breast Cancer
Phase:
No phase specified
Type:
Behavioral study, Prevention
Status:
Active
Age:
21 and ov er
Sponsor:
NCI, Other
Protocol IDs:
2007-0756
, NCT00630591
Select All on Page
1
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute